Article Details
Retrieved on: 2021-11-29 14:34:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PRNewswire/ -- iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops innovative therapies using its proprietary sublingual ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here